SOPHiA GENETICS Statistics
Want to see SOPH full AI Analyst Report?
SOPHiA GENETICS (SOPH) Stock Statistics & Valuation Metrics
Total Valuation
SOPHiA GENETICS has a market cap or net worth of $698.90M. The enterprise value is $683.97M.
- Market Cap
- $698.90M
- Enterprise Value
- $683.97M
Share Statistics
SOPHiA GENETICS has 85,127,820 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 85,127,820
- Owned by Insiders
- 8.70%
- Owned by Institutions
- 27.09%
Financial Efficiency
SOPHiA GENETICS’s return on equity (ROE) is -1.68 and return on invested capital (ROIC) is -61.34%.
- Return on Equity (ROE)
- -1.68
- Return on Assets (ROA)
- -0.48
- Return on Invested Capital (ROIC)
- -61.34%
- Return on Capital Employed (ROCE)
- -0.63
- Revenue Per Employee
- 186.20K
- Profits Per Employee
- -190.36K
- Employee Count
- 415
- Asset Turnover
- 0.47
- Inventory Turnover
- 4.64
Valuation Ratios
The current PE Ratio of SOPHiA GENETICS is -7.53. SOPHiA GENETICS’s PEG ratio is -3.43.
- PE Ratio
- -7.53
- PS Ratio
- 7.68
- PB Ratio
- 10.26
- Price to FCF
- -14.40
- Price to Operating Cash Flow
- -16.60
- PEG Ratio
- -3.43
Income Statement
In the last 12 months, SOPHiA GENETICS had revenue of 77.27M and earned -79.00M in profits. Earnings per share was -1.17.
- Revenue
- 77.27M
- Gross Profit
- 47.81M
- Operating Income
- -70.92M
- Pretax Income
- -78.49M
- Net Income
- -79.00M
- EBITDA
- -64.40M
- Earnings Per Share (EPS)
- -1.17
Cash Flow
In the last 12 months, operating cash flow was -42.28M and capital expenditures -6.24M, giving a free cash flow of -48.52M billion.
- Operating Cash Flow
- -42.28M
- Free Cash Flow
- -48.52M
- Free Cash Flow per Share
- -0.57
Dividends & Yields
SOPHiA GENETICS pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -6.94%
- Earnings Yield
- -11.56%
Stock Price Statistics
- Beta
- 1.64
- 52-Week Price Change
- 87.44%
- 50-Day Moving Average
- 7.65
- 200-Day Moving Average
- 6.07
- Relative Strength Index (RSI)
- 59.20
- Average Volume (3m)
- 659.85K
Important Dates
SOPHiA GENETICS upcoming earnings date is Mar 09, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Nov 03, 2026
- Next Earnings Date
- Mar 09, 2027
- Ex-Dividend Date
- ―
Financial Position
SOPHiA GENETICS as a current ratio of 1.96, with Debt / Equity ratio of 133.67%
- Current Ratio
- 1.96
- Quick Ratio
- 1.84
- Debt to Market Cap
- 0.15
- Net Debt to EBITDA
- 0.11
- Interest Coverage Ratio
- -15.57
Taxes
In the past 12 months, SOPHiA GENETICS has paid 512.00K in taxes.
- Income Tax
- 512.00K
- Effective Tax Rate
- -0.01
Enterprise Valuation
SOPHiA GENETICS EV to EBITDA ratio is -10.06, with an EV/FCF ratio of -13.73.
- EV to Sales
- 7.32
- EV to EBITDA
- -10.06
- EV to Free Cash Flow
- -13.73
- EV to Operating Cash Flow
- -15.76
Balance Sheet
SOPHiA GENETICS has $93.65M in cash and marketable securities with $61.04M in debt, giving a net cash position of $32.61M billion.
- Cash & Marketable Securities
- $93.65M
- Total Debt
- $61.04M
- Net Cash
- $32.61M
- Net Cash Per Share
- $0.38
- Tangible Book Value Per Share
- $0.38
Margins
Gross margin is 66.43%, with operating margin of -80.47%, and net profit margin of -89.18%.
- Gross Margin
- 66.43%
- Operating Margin
- -80.47%
- Pretax Margin
- -88.91%
- Net Profit Margin
- -89.18%
- EBITDA Margin
- -72.78%
- EBIT Margin
- -81.67%
Analyst Forecast
The average price target for SOPHiA GENETICS is $11.50, which is 11.43% higher than the current price. The consensus rating is Strong Buy
- Price Target
- $11.50
- Price Target Upside
- 40.07% Upside
- Analyst Consensus
- Strong Buy
- Analyst Count
- 3
- Revenue Growth Forecast
- 24.11%
- EPS Growth Forecast
- 2.08%
Scores
- Smart Score
- 7
- AI Score
- 53

